Effect of Race/Ethnicity on the Efficacy of Warfarin: Potential Implications for Prevention of Stroke in Patients with Atrial Fibrillation

Author： Shen Albert Yuh-Jer  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.22, Iss.10, 2008-01, pp. : 815-825

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guidelines for Stroke Prevention in Patients with Atrial Fibrillation

By Howard P.A.  

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 997-1009

Adis International

Access to resources Recommend Favorite

In patients with atrial fibrillation, warfarin therapy commenced prior to detection of left atrial thrombus (LAT) reduces the incidence of stroke

By  

Inpharma, Vol. 1, Iss. 1576, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Optimal Intensity of Anticoagulation

By Yasaka M.   Yamaguchi T.  

CNS Drugs, Vol. 15, Iss. 8, 2001-01 ,pp. : 623-631

Adis International

Access to resources Recommend Favorite

Spotlight on Dabigatran Etexilate in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation†

By Garnock-Jones Karly P.  

Drugs & Aging, Vol. 28, Iss. 5, 2011-05 ,pp. : 415-419

Adis International

Access to resources Recommend Favorite

Dronedarone: A New Hope for Stroke Prevention in Atrial Fibrillation?

By Shantsila Alena   Lip Gregory Y.H.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 355-356

Adis International

Access to resources Recommend Favorite